v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows From Operating Activities:    
Net loss $ (5,261,000) $ (17,382,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 270,000 273,000
Change in fair value of contingent consideration (185,000) 9,173,000
Non-cash lease expense 254,000 249,000
Depreciation 48,000 53,000
Deferred research and development tax credit (832,000) (851,000)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 402,000 615,000
Accounts payable (8,000) (301,000)
Accrued expenses 196,000 (602,000)
Accrued employee benefits (147,000) (427,000)
Operating lease liability (278,000) (268,000)
Net Cash Used In Operating Activities: (5,541,000) (9,468,000)
Net Cash Used in Investing Activities    
Purchase of property and equipment (3,000) (16,000)
Net Cash Used in Investing Activities (3,000) (16,000)
Cash Flows from Financing Activities:    
Tax credit receivable 1,609,000 1,798,000
Payment of loans payable (60,000) (67,000)
Proceeds from issuance of common stock under at - the - market offering, net of issuance cost 2,303,000  
Proceeds from issuance of common stock   6,690,000
Proceeds from issuance of common stock for warrant exercises   4,000
Proceeds from long term debt   1,458,000
Net Cash provided by Financing Activities 3,852,000 9,883,000
Effects of exchange rate changes on cash and cash equivalents (29,000) 62,000
Net increase (decrease) in cash and cash equivalents and restricted cash (1,721,000) 461,000
Cash, cash equivalents and restricted cash at the beginning of this period 13,102,000 11,705,000
Cash, cash equivalents and restricted cash at the end of this period 11,381,000 $ 12,166,000
Supplemental non-cash investing and financing activities    
Right of use asset obtained in exchange for lease liabilities $ 1,291,000